Myo-inositol/D-chiro-inositol Ratio in Follicular Fluid
Altered Myo-inositol/D-chiro-inositol Ratio in Follicular Fluid of Women Undergoing in Vitro Fertilization Has Detrimental Effects on Oocyte and Embryo Quality
1 other identifier
observational
34
1 country
1
Brief Summary
Considering the importance assumed by follicular microenvironment for a proper oocyte development, this study is a prospective observational clinical trial which aims to evaluate whether the embryo blastocyst quality may be affected by different Myo-inositol (MI) and D-chiro-inositol (DCI) levels in the follicular fluid (FF) of the aspired oocytes. The study includes egg donors and egg receiving couples participating in the oocyte donation program. MI/DCI is calculated in FF and related with blastocyst grade.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 8, 2017
CompletedFirst Posted
Study publicly available on registry
February 16, 2017
CompletedFebruary 16, 2017
February 1, 2017
1 month
February 8, 2017
February 13, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Myo-inositol concentration (µmol/l) in follicular fluid
After transvaginal aspiration of oocyte and follicular fluid and subsequent ICSI, at the day 5 the cultured embryos were graded according to Gardner's grading system for blastocysts. Then follicular fluids specimens were divided following the different scores given to the respective blastocysts, and their content in myo-inositol was quantified. In each sample of follicular fluid myo-inositol levels were assessed. The quantitative analysis was performed by means of gas chromatography-mass spectrometry (GC-MS) and the values were expressed as µmol/l. This value was related to the respective blastocyst grade.
5th day from pick up
D-chiro-inositol concentration (µmol/l) in follicular fluid
After transvaginal aspiration of oocyte and follicular fluid and subsequent ICSI, at the day 5 the cultured embryos were graded according to Gardner's grading system for blastocysts. Then follicular fluids specimens were divided following the different scores given to the respective blastocysts, and their content in D-chiro-inositol was quantified. In each sample of follicular fluid D-chiro-inositol levels were assessed. The quantitative analysis was performed by means of gas chromatography-mass spectrometry (GC-MS) and the values were expressed as µmol/l. This value was related to the respective blastocyst grade.
5th day from pick up
Study Arms (1)
Follicular Fluids
Follicular fluids obtained by 8 oocyte donors
Interventions
Quantitative analysis of myo-inositol was performed by gas chromatography-mass spectrometry (GC-MS)
Quantitative analysis of D-chiro-inositol was performed by gas chromatography-mass spectrometry (GC-MS)
Eligibility Criteria
The study included 8 egg donors participating in the donation program of IAKENTRO not for the first time, and 11 recipient couples undergoing in vitro fertilization (ICSI). Follicular fluid (FF) specimens were analysed.
You may qualify if:
- clear follicular aspirate obtained during oocyte retrieval;
- each specimen of follicular fluid containing only one oocyte.
You may not qualify if:
- hyperglycaemic women;
- PCOS women also if euglycaemic;
- diabetic subjects having low concentrations of detectable MI in association with an anomalous MI transport.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Iakentro Advanced Medical Centre, IVF Unit
Thessaloniki, Greece
Related Publications (4)
Chiu TT, Rogers MS, Law EL, Briton-Jones CM, Cheung LP, Haines CJ. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod. 2002 Jun;17(6):1591-6. doi: 10.1093/humrep/17.6.1591.
PMID: 12042283BACKGROUNDCarlomagno G, Unfer V, Roseff S. The D-chiro-inositol paradox in the ovary. Fertil Steril. 2011 Jun 30;95(8):2515-6. doi: 10.1016/j.fertnstert.2011.05.027. Epub 2011 Jun 8.
PMID: 21641593BACKGROUNDGardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000 Jun;73(6):1155-8. doi: 10.1016/s0015-0282(00)00518-5.
PMID: 10856474BACKGROUNDRavanos K, Monastra G, Pavlidou T, Goudakou M, Prapas N. Can high levels of D-chiro-inositol in follicular fluid exert detrimental effects on blastocyst quality? Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5491-5498. doi: 10.26355/eurrev_201712_13940.
PMID: 29243796DERIVED
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2017
First Posted
February 16, 2017
Study Start
October 1, 2016
Primary Completion
November 1, 2016
Study Completion
December 1, 2016
Last Updated
February 16, 2017
Record last verified: 2017-02